The Dual-Action Weight Loss Protocol.
Compounded Tirzepatide & Semaglutide
Free clinician review & ongoing care included with all orders.
"The initial consult was quick and easy. Down 24 lbs in 8 weeks with zero cravings."
Marcus T., Verified Patient
"The best decision I've made this year. Cold-chain delivery arrived at my door overnight."
David R., Verified Patient
"Noticeable energy boost and rapid body recomposition without losing lean muscle mass."
Jason K., Verified Patient
Clinical Specifications
INSIDE YOUR PROTOCOL
Mechanism of Action
HOW IT WORKS
ACTIVATES GLP-1
Binds to GLP-1 receptors to slow gastric emptying, reduce appetite, and promote satiety after meals.
ADDED GIP ACTION
Dual GIP receptor agonist activity accelerates fat breakdown and improves metabolic insulin sensitivity.
TITRATED TO YOU
Your dedicated physician gradually increases dosage month-by-month for smooth, sustainable fat loss.
Evidence-Based
WHAT THE RESEARCH SAYS
SURMOUNT-1 Phase 3 Clinical Trial
"Patients receiving maximum tolerated doses achieved an average weight reduction of up to 20.9% over 72 weeks."
Source: New England Journal of Medicine (NEJM)
Metabolic Rate & Visceral Fat Reduction
"Significant reduction in deep visceral adipose tissue with marked improvements in cardiovascular lipid markers."
Source: Journal of Clinical Endocrinology & Metabolism
GLP-1 receptor agonists are contraindicated in patients with a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Common side effects may include mild nausea, constipation, or indigestion, which typically subside as dosage titrates.
Common Questions
PROTOCOL FAQ
WEIGHT LOSS & METABOLIC RECOMPOSITION